CHI Logo
Shop
Checkout
Header Graphic
February 4, 2012
| Insight Pharma Reports > Enabling Technology And Diagnostics

Enabling Technology & Diagnostics


High-Content Analysis Report
December 2011
Table of Contents | Tables and Figures


Engineering Next-Generation Therapeutic Proteins
July 2011
Table of Contents | Tables and Figures


Next Generation Sequencing Generates Momentum
July 2011
Table of Contents


Next Generation Mass Spectrometry
July 2011
Table of Contents | Tables and Figures | Executive Summary
Multitargeted Therapies
June 2011
Table of Contents | Tables and Figures


Commercializing Biomarkers in Therapeutic and Diagnostic Applications
May 2011
Table of Contents | Tables and Figures | Executive Summary


Molecular Diagnostics
February 2011
Table of Contents | Tables and Figures | Executive Summary


Advanced Drug Delivery Technologies
January 2011
Table of Contents | Tables and Figures | Executive Summary


RNAi Therapeutics
October 2010
Table of Contents | Tables and Figures | Executive Summary


Next-Generation Sequencing Technologies: Applications and Markets
October 2010
Table of Contents | Tables and Figures | Executive Summary


Therapeutic Protein Production: A Changing Landscape
July 2010
Table of Contents | Tables and Figures | Executive Summary


Epigenetic Drug & Diagnostic Pipelines
June 2010
Table of Contents | Tables and Figures | Executive Summary


Cloud Computing in Life Sciences R&D
April 2010
Table of Contents | Tables and Figures


Combination Drug/Diagnostics: Fueling Growth of Personalized Medicine
April 2010
Table of Contents | Tables and Figures | Executive Summary


Animal Models for Therapeutic Strategies
March 2010
Table of Contents | Tables and Figures | Executive Summary


Multiplex Assays: Evolving Technologies, Applications and Future Directions
January 2010
Table of Contents | Tables and Figures | Executive Summary


Data Mining in Drug Development and Translational Medicine
July 2009
Table of Contents | Tables and Figures | Executive Summary
Next-Generation Sequencing: Solving the Genome
June 2009
Table of Contents | Tables and Figures | Executive Summary


Bioinformatics and Computational Biology: Bottlenecks and Options
June 2009
Table of Contents | Tables and Figures | Executive Summary
Pharmacogenomics: Delivering on the Promise
June 2009
Table of Contents | Tables and Figures | Executive Summary
Medicinal Chemistry for Drug Discovery: Significance of Recent Trends
March 2009
Table of Contents | Tables and Figures | Executive Summary
Direct-To-Consumer Genetic Testing: Business Prospects in the United States
March 2009
Table of Contents | Tables and Figures | Executive Summary
Molecular Diagnostics: A Dynamic and Rapidly Broadening Market
January 2009
Table of Contents | Tables and Figures | Executive Summary


Biomedical Imaging: From Drug Target Discovery to Medical Diagnostics
December 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Stem Cells Come of Age
November 2008
Table of Contents | Tables and Figures | Executive Summary

GPCRs: Dawn of a New Era?
October 2008
Table of Contents | Tables and Figures | Executive Summary


Cancer Biomarkers: Adoption Is Driving Growth
July 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Systems Biology: A Disruptive Technology
May 2008
Table of Contents | Tables and Figures | Executive Summary

Blood-Brain Barrier: Bridging Options for Drug Discovery & Development
May 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Cardiotoxicity: Issues, Technologies, and Solutions for the Future
May 2008
Table of Contents | Tables and Figures | Executive Summary

MicroRNAs: Commercial Products on the Horizon
March 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Epigenetics: Technologies, Applications, and the Commercial Landscape
February 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Multiplex Assays in Translational Medicine: Technologies, Applications, and Future Directions
February 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Molecular Imaging in Drug R&D and Medical Practice
January 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Molecular Diagnostics: A Rapidly Shifting Commercial and Technology Landscape
November 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Next-Generation Sequencing: Scientific and Commercial Implications of the $1000 Genome
August 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary
Clinical Forecasting: A Novel Bayesian Tool for Predicting Phase III Outcomes
July 2007
Table of Contents | Tables and Figures | Executive Summary
Disease-Related Biomarkers: Their Potential in Patient Screening, Prognosis, and Stratification
June 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Combination Drug/Diagnostic Products: Pathways to R&D and Commercial Success
May 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

High-Content Analysis: Technologies, Applications, Market Analysis
May 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Delivery Technologies for Therapeutic Proteins: Assessment and Outlook
March 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Biomarker SOPs: Getting Optimum Value from Your Biomarker Program
January 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary
Outlook for Predictive Safety Technologies
November 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Comparative Genomic Hybridization: Current State and Future Directions
September 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary
Proteomics: Current State and Future Directions
September 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary
Microdosing in Translational Medicine: Pros and Cons
May 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

The Impact of Genomics on Clinical Trials and Medical Practice
April 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Multiplex Assays: Technologies, Applications, and Markets
April 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Oncogenomics: The Future of Cancer Cure
January 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Molecular Diagnostics: New Growth, New Markets
November 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Cancer Diagnostics: Technology and Business Trends
October 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Pharmacodiagnostics: Technologies: Technologies, Competition, and Market Models
July 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Nutrigenomics: Impacts on Markets
June 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Cardiovascular Diagnostics: Key Developments in Technologies and Markets
May 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Neurogenomics and Neurotherapeutic Strategies: New Directions in Platforms, Targets, and Therapeutic Approaches
March 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Cambridge Healthtech Institute

Footer Image
  • 250 First Avenue, Suite 300
  • Needham MA 02494
  • phone: 781-972-5400
  • fax: 781-972-5425
  • chi@healthtech.com